Jane Street
EDSA icon

Jane Street’s Edesa Biotech EDSA Stock Holding History

Jane Street’s Portfolio EDSA Stock Details EDSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$589K Sell
72,465
-43,256
-37% -$390K ﹤0.01% 7648
2026
Q1 		$605K Buy
+115,721
New +$347K ﹤0.01% 7595
2018
Q4 		– Sell
-487
Closed -$28K – 5102
2018
Q3 		$28K Buy
+487
New +$31K ﹤0.01% 4958

Other funds holding EDSA

VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jane Street's EDSA Position: Q2 2026 in Review

Jane Street reduced its Edesa Biotech (EDSA) stake by 37% in Q2 2026, selling an estimated $390K and leaving 72,465 shares worth $589K. The position accounts for ﹤0.01% of the portfolio, ranked #7648.

Jane Street first reported a position in EDSA in Q3 2018 and has held it in 3 quarters since. The position peaked at $605K in Q1 2026. 30 funds tracked by Wall St. Rank hold EDSA as of Q2 2026.

  • Jane Street held 72,465 shares of Edesa Biotech worth $589K as of Q2 2026.
  • Jane Street sold 43,256 Edesa Biotech shares in Q2 2026, an estimated $390K.
  • Edesa Biotech made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #7648 holding.
  • Jane Street first reported a position in Edesa Biotech in Q3 2018 and has held it in 3 quarters since.
  • Jane Street's Edesa Biotech position peaked at $605K in Q1 2026.
  • 30 funds tracked by Wall St. Rank held Edesa Biotech as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.